2023
DOI: 10.1002/jbm4.10749/v2/response1
|View full text |Cite
|
Sign up to set email alerts
|

Author response for "Prevalence of Precursory Signs of Atypical Femoral Fractures in Patients Receiving Bone‐Modifying Agents for Bone Metastases: A Cross‐Sectional Study"

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles